Literature DB >> 638041

Erythropoietic protoporphyria: hepatic cirrhosis.

D J Cripps, S S Goldfarb.   

Abstract

Observations on liver pathology and function were made on 12 patients with erythropoietic protoporphyria (EPP). Needle liver biopsies in 3 of 11 patients showed mild portal or periportal fibrosis without evidence of abnormal liver function. One patient (Case 12), died from hepatic cirrhosis and failure at the age of 11 years, the youngest yet reported. He was not suspected of pending liver disease until 3 months before death. The quantity of protoporphyrin present in his liver was approximately 5.75% of total liver weight. Fatal liver disease in EPP has occurred in 13 patients, 7 male and 6 female, in which the mean age of death was 38 years. The pathology of the liver in EPP is characteristic and is described.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638041     DOI: 10.1111/j.1365-2133.1978.tb06163.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

2.  Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.

Authors:  M B Poh-Fitzpatrick; J A Sklar; C Goldsman; J H Lefkowitch
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

3.  Uptake of protoporphyrin IX by isolated rat liver mitochondria.

Authors:  M E Koller; I Romslo
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

4.  Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.

Authors:  D L Avner; R G Lee; M M Berenson
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.